ZASLOFF MICHAEL A - 05 Mar 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
05 Mar 2024
Transactions value $
$-589,724
Form type
4
Filing time
06 Mar 2024, 17:57:25 UTC
Previous filing
16 Aug 2023
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Sale $-441,871 -9,389 -27.8% $47.06 24,437 05 Mar 2024 Direct F1
transaction AMPH Common Stock Sale $-147,853 -3,111 -12.7% $47.53 21,326 05 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.435 to $47.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.435 to $47.68, inclusive.